advertisement
Mermoud A 18
Showing records 1 to 18 | Display all abstracts from Mermoud A90162 XEN-augmented Baerveldt drainage device implantation in refractory glaucoma: 1-year outcomes
Bravetti GE
Graefe's Archive for Clinical and Experimental Ophthalmology 2020; 258: 1787-1794
90295 A Prospective Analysis of iStent Inject Microstent Implantation: Surgical Outcomes, Endothelial Cell Density, and Device Position at 12 Months
Gillmann K
Journal of Glaucoma 2020; 29: 639-647
90792 Combined and stand-alone XEN 45 gel stent implantation: 3-year outcomes and success predictors
Gillmann K
Acta Ophthalmologica 2021; 99: e531-e539
90841 Goniowash: a new surgical approach combined with cataract surgery to lower intraocular pressure in pseudoexfoliation syndrome
V Tran T
International Ophthalmology 2021; 41: 1563-1571
90162 XEN-augmented Baerveldt drainage device implantation in refractory glaucoma: 1-year outcomes
Mansouri K
Graefe's Archive for Clinical and Experimental Ophthalmology 2020; 258: 1787-1794
90841 Goniowash: a new surgical approach combined with cataract surgery to lower intraocular pressure in pseudoexfoliation syndrome
Mansouri K
International Ophthalmology 2021; 41: 1563-1571
90295 A Prospective Analysis of iStent Inject Microstent Implantation: Surgical Outcomes, Endothelial Cell Density, and Device Position at 12 Months
Mansouri K
Journal of Glaucoma 2020; 29: 639-647
90792 Combined and stand-alone XEN 45 gel stent implantation: 3-year outcomes and success predictors
Bravetti GE
Acta Ophthalmologica 2021; 99: e531-e539
90841 Goniowash: a new surgical approach combined with cataract surgery to lower intraocular pressure in pseudoexfoliation syndrome
Mermoud A
International Ophthalmology 2021; 41: 1563-1571
90792 Combined and stand-alone XEN 45 gel stent implantation: 3-year outcomes and success predictors
Rao HL
Acta Ophthalmologica 2021; 99: e531-e539
90162 XEN-augmented Baerveldt drainage device implantation in refractory glaucoma: 1-year outcomes
Gillmann K
Graefe's Archive for Clinical and Experimental Ophthalmology 2020; 258: 1787-1794
90295 A Prospective Analysis of iStent Inject Microstent Implantation: Surgical Outcomes, Endothelial Cell Density, and Device Position at 12 Months
Ambresin A
Journal of Glaucoma 2020; 29: 639-647
90162 XEN-augmented Baerveldt drainage device implantation in refractory glaucoma: 1-year outcomes
Rao HL
Graefe's Archive for Clinical and Experimental Ophthalmology 2020; 258: 1787-1794
90295 A Prospective Analysis of iStent Inject Microstent Implantation: Surgical Outcomes, Endothelial Cell Density, and Device Position at 12 Months
Bravetti GE
Journal of Glaucoma 2020; 29: 639-647
90792 Combined and stand-alone XEN 45 gel stent implantation: 3-year outcomes and success predictors
Mermoud A
Acta Ophthalmologica 2021; 99: e531-e539
90295 A Prospective Analysis of iStent Inject Microstent Implantation: Surgical Outcomes, Endothelial Cell Density, and Device Position at 12 Months
Mermoud A
Journal of Glaucoma 2020; 29: 639-647
90162 XEN-augmented Baerveldt drainage device implantation in refractory glaucoma: 1-year outcomes
Mermoud A
Graefe's Archive for Clinical and Experimental Ophthalmology 2020; 258: 1787-1794
90792 Combined and stand-alone XEN 45 gel stent implantation: 3-year outcomes and success predictors
Mansouri K
Acta Ophthalmologica 2021; 99: e531-e539
